Complications of invasive mycoses in organ transplant recipients (Q38969056)

8 September 2017

1 reference

title

Complications of invasive mycoses in organ transplant recipients (English)

1 reference

8 September 2017

1 reference

Palash Samanta

1

1 reference

8 September 2017

Nina Singh

series ordinal

2

1 reference

8 September 2017

publication date

3 October 2016

1 reference

Expert Review of Anti-infective Therapy

8 September 2017

published in

1 reference

8 September 2017

volume

14

1 reference

8 September 2017

issue

12

1 reference

8 September 2017

page(s)

1195-1202

1 reference

Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

The economic costs to United States hospitals of invasive fungal infections in transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Candidemia following solid organ transplantation in the era of antifungal prophylaxis: the Australian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Risk factors for invasive aspergillosis in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Fungal infections in solid-organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Trends in invasive disease due to Candida species following heart and lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Diagnosis and outcome of early pleural space infection following lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Donor-derived disease transmission events in the United States: data reviewed by the OPTN/UNOS Disease Transmission Advisory Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Outcome of renal transplantation in eight patients with Candida sp. contamination of preservation fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Evidence That Graft‐Site Candidiasis after Kidney Transplantation Is Acquired during Organ Recovery: A Multicenter Study in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Donor-derived filamentous fungal infections in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Fungal infections after liver transplantation: outcomes and risk factors revisited in the MELD era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Pretransplant model for end stage liver disease score predicts posttransplant incidence of fungal infections after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Hypogammaglobulinemia in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Cytomegalovirus Infection Is a Risk Factor for Invasive Aspergillosis in Lung Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Candidemia in the intensive care unit: analysis of direct treatment costs and clinical outcome in patients treated with echinocandins or fluconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Invasive fungal infections in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

The impact of candidemia on length of hospital stay, outcome, and overall cost of illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Impact of first-line antifungal agents on the outcomes and costs of candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Resource utilization and cost of treatment with anidulafungin or fluconazole for candidaemia and other forms of invasive candidiasis: focus on critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Epidemiology of candidemia in intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Comparison of costs, length of stay, and mortality associated with Candida glabrata and Candida albicans bloodstream infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Anidulafungin versus fluconazole for invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

The direct cost and incidence of systemic fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

The economic impact of aspergillosis: analysis of hospital expenditures across patient subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Opportunistic infection-associated immune reconstitution syndrome in transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Immune reconstitution syndrome associated with opportunistic mycoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Cellulitis Revealing a Cryptococcosis-Related Immune Reconstitution Inflammatory Syndrome in a Renal Allograft Recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Immune reconstitution syndrome-like entity in lung transplant recipients with invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Immune reconstitution inflammatory syndrome after cessation of the tumor necrosis factor alpha blocker adalimumab in cryptococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Immune reconstitution syndrome after voriconazole treatment for cryptococcal meningitis in a liver transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Adjuvant corticosteroid therapy for chronic disseminated candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Adjuvant corticosteroid therapy in 2 children with hepatosplenic candidiasis-related IRIS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Immune reconstitution pneumonitis following Pneumocystis carinii pneumonia in HIV-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Immunocompromised hosts: immunopharmacology of modern antifungals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Invasive aspergillosis in glucocorticoid-treated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Liposomal amphotericin B activates antifungal resistance with reduced toxicity by diverting Toll-like receptor signalling from TLR-2 to TLR-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

The impact of antifungals on toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Immunomodulatory effects of voriconazole on monocytes challenged with Aspergillus fumigatus: differential role of Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Randomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: implications for the management of immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Antifungal prophylaxis in liver transplant patients: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Antifungal management practices in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Caspofungin versus fluconazole as prophylaxis of invasive fungal infection in high-risk liver transplantation recipients: A propensity score analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Nebulized amphotericin B concentration and distribution in the respiratory tract of lung-transplanted patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

10 years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology of Aspergillus spp. infection in lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Antifungal prophylaxis with voriconazole or itraconazole in lung transplant recipients: hepatotoxicity and effectiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Anti-Aspergillus Prophylaxis in Lung Transplantation: A Systematic Review and Meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Duration of voriconazole exposure: an independent risk factor for skin cancer after lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Periostitis secondary to prolonged voriconazole therapy in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Posaconazole in lung transplant recipients: use, tolerability, and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

A pharmacokinetic analysis of posaconazole oral suspension in the serum and alveolar compartment of lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Molecular Characterization of a Voriconazole-Resistant, Posaconazole-Susceptible Aspergillus fumigatus Isolate in a Lung Transplant Recipient in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Scedosporium prolificans pericarditis and mycotic aortic aneurysm in a lung transplant recipient receiving voriconazole prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Multidrug-resistant endemic clonal strain of Candida auris in India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Antifungal Use and Therapeutic Monitoring of Plasma Concentrations of Itraconazole in Heart and Lung Transplantation Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Trends in Risk Profiles for and Mortality Associated with Invasive Aspergillosis among Liver Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Risk Factors for Invasive Aspergillosis in Solid-Organ Transplant Recipients: A Case-Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

Life-threatening immune reconstitution inflammatory syndrome after Pneumocystis pneumonia: a cautionary case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/14787210.2016.1242412

10.1080/14787210.2016.1242412

21 January 2018

Identifiers

DOI

1 reference

8 September 2017

1 reference